Introduction
Wnt signaling drives cell fate decisions, proliferation/ survival activities and changes in cell shape. Aberrant Wnt signaling during embryogenesis yields tractable developmental and pattern abnormalities, a selective advantage in flies and worms, in which much of the Wnt/wingless signal transduction system has been defined. In post-natal tissues that are continually replenished by long-lived stem cell niches, problems with Wnt signaling can lead to disease, most prominently cancer. LEF/TCFs are sequence-specific DNAbinding transcription factors that function in the Wnt signaling pathway by recruiting b-catenin to Wnt target genes. b-Catenin has potent transcription activation domains at the N-and C-termini, but it has no intrinsic ability to bind to DNA, thus, it relies on interactions with DNA-binding factors to regulate gene expression. There are other transcription factors that bind to b-catenin, but genetic manipulation of LEF/TCFs closely mimics the effects of similar manipulations of Wnt ligands and receptors demonstrating that this family is the most common mediator of Wnt signals. Nonvertebrate systems such as flies, worms and earlier diverging species such as Hydra and Ciona express a single LEF/TCF ortholog (dTCF/pangolin, POP-1, and hyTCF, ciTCF, respectively), but higher organisms have four family members: TCF-1, LEF-1, TCF-3 and TCF-4 (although zebrafish have at least five: zTCF-1, zLEF-1, zTCF-3b, Headless and zTCF-4), (see references in Hurlstone and Clevers (2002) , Waterman (2004) , Veien et al. (2005) ). LEF/TCFs are produced as a group of isoforms through alternative splicing and promoter usage, and Figure 1 presents their basic domain structure and diverse isoforms.
b-Catenin-binding domain
The N-terminal b-catenin-binding domain (amino acids (aa) 1-50) is highly conserved (B60% sequence identity among orthologs), and all LEF/TCFs bind b-catenin. Binding involves induced conformational changes in the first 50 aa via formation of an alpha helix and salt bridges with charged residues ('buttons') in the superhelically formed interaction groove of the central Armadillo repeat domain (Graham et al., 2000 (Graham et al., , 2001 . In fact, circular dichroism spectra and protease digestion experiments show that LEF/TCFs are largely unfolded proteins in solution and only adopt folded structures when engaged in authentic interactions (Daniels and Weis, 2005) , (B Weis, personal communiction). Such observations emphasize how unfolded LEF/TCFs might be especially prone to weak, biologically irrelevant interactions, and underscore the importance of rigorous controls for in vitro and in vivo binding assays. LEF/TCFs can also bind to g-catenin/ plakoglobin, a highly related, but distinct catenin (Zhurinsky et al., 2000) . Binding is weaker than for b-catenin and occurs through a region C-terminal to the b-catenin-binding domain (aa 51-80) (Miravet et al., 2002) . Casein kinase 2 phosphorylation of serine60 in TCF-4, a serine not in other LEF/TCFs, inhibits g-catenin binding, but the biological relevance of this phosphorylation and the overall effect on Wnt signaling are not settled. In fact, the overall role of g-catenin in Wnt activities are not settled; depletion of g-catenin in Xenopus and mice does not affect Wnt signaling, but g-catenin/TCF complexes are more effective activators of c-MYC expression in immortalized cells, where it has oncogenic actions (Kolligs et al., 2000) . 15-20%. However, all vertebrate LEF/TCFs have an alternative exon in this region (constitutive in lower organisms). The function of this exon is unknown but recent data suggest that it is recognized by an antagonist-acting protein (Ghogomu et al., 2006) . Similarly, some family members have additional alternative splice donor and acceptor sites upstream and downstream such that the alternative exon can be flanked by small amino-acid motifs (LPVQ and SxxSS), and here the functional significance has been defined for transcription repression (Pukrop et al., 2001; Gradl et al., 2002; Liu et al., 2005) . More generally, the CRD participates in repression by recruiting the pleiotropic repressor Groucho (transducin-like enhancer of split, TLE, in human) (Cavallo et al., 1998; Levanon et al., 1998; Roose et al., 1998) . It may seem that the CRD functions more as a context-dependent repression domain, but in fact this region also engages in cooperative interactions with transcription activators. Thus, context-dependent regulatory domain is a more accurate definition of the CRD acronym -a reflection of the diverse sequence and roles of this region.
HMG DNA bending/binding LEF/TCFs exhibit remarkable amino-acid sequence conservation in the high-mobility group DNA-binding domain (HMG; B95-99% sequence identity) and nuclear localization signal (NLS). The NLS is recognized directly by importin alpha subunits for nuclear import, and there are differences between LEF/TCFs in this interaction (Prieve et al., 1998) . Once in the nucleus, however, all LEF/TCFs bind to the consensus sequence CCTTTGWW. The HMG box recognizes its site in the minor groove, and the nuclear localization signal contacts the phosphate backbone to elevate DNA binding 100-fold. This cooperation results in nanomolar affinity for the DNA sequence, a value that is merely 20-to 40-fold above its affinity for any double-stranded DNA (Giese et al., 1991; van de Wetering and Clevers, 1992; Love et al., 1995) . DNA site selection experiments with the HMG DNA-binding domain of dTCF/pangolin and TCF-1 defined the core recognition sequence and determined that the consensus is nearly identical for all LEF/TCFs -an unsurprising result given that the HMG DNA-binding domains are so remarkably conserved (van de Wetering et al., 1997; van Beest et al., 2000) . Mutation of the 3 0 W residues or more than one central T residue reduces binding by at least 10-to 20-fold, and, therefore, these mutations are commonly used to destroy LEF/TCF recognition of WREs (Oosterwegel et al., 1991; Giese et al., 1992) . One important activity often neglected is that LEF/TCFs bend DNA dramatically (1301 for LEF-1) (Giese et al., 1992; Love et al., 1995) . Indeed, early studies of LEF/TCF action led to a model in which bending was the salient feature driving its gene regulatory activities in lymphocytes. Bending is essential for contacts between transcription factors binding on either side; for example, no rearrangement of the LEF/TCF site from the center of the T-cell receptor alpha chain enhancer can be tolerated and heterologous DNA bending proteins can partially rescue activity (Grosschedl et al., 1994; Giese et al., 1995) . Interestingly, removal of the N-terminal region of LEF/ TCFs had an enhancing effect in this situation -a fact that emphasizes how LEF/TCFs can activate gene transcription outside the realm of Wnt signaling (Carlsson et al., 1993) . It would be several years more before this 'inhibitory domain' was discovered to function as a b-catenin-binding domain -the molecular tether that links LEF/TCFs to the Wnt signaling pathway (Behrens et al., 1996; Huber et al., 1996; Molenaar et al., 1996; Brunner et al., 1997; van de Wetering et al., 1997) .
Alternatively spliced C-terminal tails Vertebrate LEF/TCFs are expressed with different alternatively spliced C-termini (Figure 1 ), Duval et al., 2000; Hovanes et al., 2000) . Until recently, the relevance of any one of these tails to LEF/TCF activities was not known. (green) is absent in dominant negative isoforms (dnTCF-1, dnLEF-1), which are produced by alternative promoters Hovanes et al., 2001) . A context-dependent regulatory domain (CRD; grey/yellow) separates the b-catenin-binding domain from the high-mobility group DNA-binding domain and nuclear localization signal (HMG, NLS). An internal exon in the CRD (yellow) is alternative in all members except for TCF-3, and the exon is flanked by small amino acid motifs (LVPQ, SxxSS; only in TCF-3 and TCF-4) also created by alternative splicing (Pukrop et al., 2001) . Part of the LEF-1 CRD is alternatively spliced in response to TGF-b signaling (Cordray and Satterwhite, 2005) . Alternative splicing creates different C-termini (blue; only the most common tails are shown), and the CRARF domain (dark blue) is a 33 aa motif in the E-tail conserved among all non-vertebrate orthologs but not present in vertebrates LEF-1 and TCF-3. The E-tail also contains two CtBPbinding motifs (purple) in TCF-3 and TCF-4. TCF-4N is an alternatively spliced isoform that truncates the protein before the HMG DNA-binding domain (Kennell et al., 2003) . HUGO nomenclature for the mammalian genes is indicated in parantheses.
Diverse transcription regulation by LEF/TCFs L Arce et al However, the 'E' tail, which is produced from TCF genes, but not LEF1, encodes a non-sequence specific DNA-binding domain and a region that facilitates p300 interactions (Atcha et al., 2003; Hecht and Stemmler, 2003; Atcha et al., submitted) . This tail is essential for regulation of some gene targets but not others (see below) and because it is the obligate C-terminus for dTCF, POP-1, hyTCF and ciTCF, it is likely to be the ancestral form. The alternative 'B' tail appears in all vertebrate LEF/TCFs with the exception of TCF-3 (in fact, no alternative splicing for TCF-3 has been reported). Although frequently expressed, the B tail has no known function and this is true for other, less common tails (not shown). The LEF/TCF tails are one of the least understood features, and part of the reason is that artificial reporter plasmids with optimal multimerized WREs have been the most common 'target gene' to study LEF/TCF action. Activation of these reporters is tail independent. As more groups study regulation of endogenous genes, differences between LEF/TCFs and functions for the C-termini might be discovered.
Genetic evidence for LEF/TCF diversity

Frogs and fish
Evidence for diverse actions of LEF/TCFs comes from genetic experiments in mice, zebrafish and frogs, in which LEF/TCFs are expressed in overlapping patterns. Experiments in Xenopus and zebrafish embryos provide the strongest evidence for diversity. For example, ventral overexpression of xLEF-1, but not xTCF-3 or xTCF-4, can induce a secondary axis in Xenopus. Interestingly, the source of the non-redundancy resides in the presence of the alternative internal exon and its flanking LVPQ/SxxSS motifs in the TCFs (Gradl et al., 2002) . To summarize a great deal of elegant work in early stages of frog and fish development: LEF-1 functions in a Wnt-dependent activating role, TCF-1 and TCF-4 have dual activities as repressor and activator, respectively, and TCF-3 functions as a repressor (Dorsky et al., 2002; Houston et al., 2002; Roel et al., 2002; Dorsky et al., 2003; Kunz et al., 2004; Liu et al., 2005) . Maternal xTCF-4 may be primarily an activator, but knockdown at later stages detects more varied actions suggesting that LEF/TCF functions vary temporally (Gradl et al., 2002; Kunz et al., 2004; Standley et al., 2006) . Interestingly, the LVPQ and SxxSS motifs in the CRD of TCF-3 and TCF-4 are necessary for repressor activity, and since other family members (LEF-1, TCF-1) do not generate these motifs, there are clear distinctions in family member capabilities (Gradl et al., 2002; Liu et al., 2005) . It is important to note that Wnt stimulation relieves xTCF-3 (and possibly xTCF-1) repression of dorsal genes, not by converting xTCF-3 into an activator, but by negating its function, so that other transcription activators such as the homeodomain factor VegT can activate target genes (Houston et al., 2002; Standley et al., 2006) . This is quite reminiscent of Wnt signaling in worms. The Caenorhabditis elegans ortholog POP-1 represses target genes, and Wnt signaling relieves repression by forcing POP-1 to leave the nucleus so that the gene can be activated by other factors (Lo et al., 2004; Shetty et al., 2005) . (It is not always repression for POP-1; recently, this ortholog has been discovered to function in activation with the homeoprotein PAL-1/Caudal (Maduro et al., 2005) .) It may be that TCFs such as TCF-3 and POP-1 function widely as repressors with less common roles in activation.
Mice Deletion of LEF/TCFs genes in mice also points to diverse roles (for a review see van Noort and Clevers (2002)). For example, both LEF-1 and TCF-1 are expressed in developing mouse thymocytes, but removal of TCF-1 yields a phenotype (albeit leaky) even though LEF-1 continues to be expressed (van Genderen et al., 1994; Verbeek et al., 1995) . A complete block in early thymocyte differentiation (intermediate single positive stage) can be achieved with removal of both TCF-1 and LEF-1 (Okamura et al., 1998) . Likewise, experiments with natural killer T cells show that LEF-1 and TCF-1 are partially redundant, but with TCF-1 contributing more to NK cell development (Held et al., 2003) . Both proteins are also redundant in early steps of embryogenesis, because the phenotype of the double knockout phenocopies a Wnt3a À/À knockout at e9.5 (defects in paraxial mesderm, limb buds and multiple neural tubes), (Galceran et al., 1999) . In the intestine, deletion of the TCF-4 gene causes a striking abrogation of stem cell compartments (Korinek et al., 1998a) . However, deletion of the co-expressed TCF-1 family member has no effect until months after birth when adenomas form (Roose et al., 1999) . Therefore, in the intestine, TCF-4 promotes stem cell maintenance and cell growth, and TCF-1 exerts an opposing tumor suppressor-like activity. TCF-3, probably the most enigmatic family member, exhibits strong, non-redundant actions in early development (Merrill et al., 2004; Pereira et al., 2006) . Problems with AP axis formation (such as complete duplication of the primitive streak and neural grooves) are readily detectable at early embryonic stages (e7.5-e8.5) and importantly, some aberrant structures phenocopy ectopic Wnt signaling. TCF-3 is expressed early and widely, explaining the timing and degree of these effects, but also a careful analysis of the knockout phenotype shows that TCF-3 acts as a repressor of target genes that are activated, not by Wnt signaling, but by other mechanisms (Korinek et al., 1998b; Merrill et al., 2004; Pereira et al., 2006) . TCF-3 is also expressed in a stem cell niche aside the shaft of hair follicles and, again, its repressor action, not Wnt-directed gene activation, is necessary for maintenance of this compartment (DasGupta and Fuchs, 1999; Merrill et al., 2001) . The non-redundant repressor actions of TCF-3 require the CRD and HMG domains, but not the b-catenin-binding domain or C-terminus (Merrill et al., 2001) . So, either TCF-3 is a dedicated repressor wholly distinct from its other family members, or it is an activator with non-redundant repressor activities. Evidence from the TCF-3 knockout mouse suggests the latter, making TCF-3 similar to POP-1 in its spectrum of actions (Merrill et al., 2004) . It is possible that human TCF-4 functions in a similar repressive manner in the breast. Depletion of TCF-4 enhanced expression of the CD24 gene, and WRE elements were important in this regulation (Shulewitz et al., 2006) . Interestingly, TCF-4 expression is frequently downregulated in primary breast cancers. It is important to emphasize that the varied activities of LEF/ TCF isoforms are not observed with TOPFLASH assays, in which all isoforms activate expression of this luciferase reporter plasmid when co-expressed with b-catenin. Thus, complexity of LEF/TCF action must be due to context-dependent actions and differential recognition of endogenous target genes. What follows for the remainder of this review are examples of diversity in LEF/TCF interactions with DNA, co-regulators and antagonists. The intent is to illustrate how Wnt signaling in the nucleus can be shaped by this diversity.
Target gene recognition
LEF/TCF recognition of DNA can occur independently but weakly within a chromatin context and with only moderate specificity. Such features virtually demand that LEF/TCFs cooperate with other factors to bind more tightly and specifically to the correct set of target genes. Indeed early studies established that LEF/TCFs cooperate with nearby factors to bind to their own sites, and at least one study has shown that interaction with b-catenin enables LEF-1 to bind more tightly to a chromatinized template (Carlsson et al., 1993; Giese et al., 1995; Tutter et al., 2001) . Context dependence of a multimerized binding site was also demonstrated in Drosophila in which overexpressed LEF-1 could not work with Armadillo (b-catenin) to activate an integrated multimerized WRE reporter gene unless a dpp responsive element was included in the multimer (Riese et al., 1997) . Thus, in these early studies, LEF/TCFs were referred to as 'context dependent' transcription activators cooperating with other factors to bind DNA and bend the template to establish productive interactions for the creation of enhanceosomes. Is there any diversity in DNA recognition? The answer is unequivocally yes. In Drosophila, the dTCF/pangolin gene produces two isoforms (panA and panB) that differ in the HMG DNA-binding domain (van de Wetering et al., 1997) . Alternative splicing chooses between two exons of which each code for the second half of the HMG box. This creates HMG boxes with divergent amino-acid sequences in the second half, and it almost certainly means that properties of DNA binding and bending will differ. This intriguing aspect of dTCF/pangolin remains unexplored. In mammalian systems, diversity in target gene recognition tracks with the alternatively spliced E tail. At least two gene targets, the LEF1 and CDX1 genes, are activated by b-catenin only when it is recruited to target genes by alternatively spliced isoforms of TCF-1 and TCF-4 that contain the E tail (Figure 1 ), (Atcha et al., 2003; Hecht and Stemmler, 2003) . The newly identified DNA-binding domain in the E tail is important for activation because it enables stable association with WREs that vary from the consensus and mutation of the motif destroys b-catenin activation (Atcha et al., submitted) . Only the genes for TCF-1 and TCF-4 code for this second DNA-binding domain, and only as an alternatively spliced isoform. Thus, LEF-1 isoforms, TCF-3 isoforms and other splice variants of TCF-1 and TCF-4 are unlikely to bind independently to as many variable WREs as TCF-1E and TCF-4E. This does not necessarily mean that LEF-1 and TCF-3 do not act broadly -rather, it predicts that these family members must rely on cooperative interactions with other factors to bind to weak Wnt response elements. Whether E-tail isoforms exert broad, more independent regulatory effects than other LEF/TCFs is currently being tested. Interestingly, the fly, worm, Hydra and Ciona orthologs, all carry the E tail and its DNA-binding motif as an obligate C-terminus. This suggests that the primordial form of LEF/TCFs carries two DNA-binding domains and that more complex organisms have relegated this form to an alternative choice. Why would a family of transcription factors relinquish this important tail from being a standard feature? Perhaps increased complexity in vertebrates requires that LEF/TCFs rely more on cooperative interactions with other factors and pathways, rather than acting as an independent regulator.
LEF/TCF co-activators
Most of the co-activator proteins that activate transcription have been found to bind directly to the N-and C-termini of b-catenin (see references in Hurlstone and Clevers (2002) , Willert and Jones (2006) ). However, cooperative interactions between LEF/TCFs and other transcription factors influence binding to targets and/or transcription activation, and it is surprising that many of the reported interactions involve LEF-1. Only a few examples are mentioned here to illustrate several principles (Wnt-independent actions, LEF-1-specific interactions) and highlight several families of cooperating factors (Ets, SMADs and homeodomain factors). In a manner independent of Wnt signaling, LEF-1 cooperates with a non-DNA-binding co-activator ALY and DNA-binding proteins (Ets/Runx1/CBF) to nucleate an enhanceosome for the T-cell receptor alpha chain gene, or with Ets, TFE-3 and Sp1 to regulate the HIV-1 promoter Bruhn et al., 1997; Balmelle et al., 2004) . Bending is not the only important activity because sequences in the CRD, including the alternative exon, are necessary for full enhanceosome activity (Carlsson et al., 1993; Sheridan et al., 1995) . LEF-1 might be particularly suited for cross-talk with Ets proteins because it cooperates with Ets family members (PEA3/ERM/ER81) for Wnt regulation of the MMP7 promoter (Crawford et al., 2001) , the Osteopontin promoter (El-Tanani et al., 2004) , and the Xcad3 promoter (Xenopus caudal) (Haremaki et al., 2003) . LEF-1 also cooperates with SMADs bound to neighboring elements to mediate Wnt and TGF-b/BMP regulation of gene targets (Labbe et al., 2000; Nishita et al., 2000; Hussein et al., 2003) . However, whether these interactions are strictly LEF-1-specific is unlikely since interactions between SMAD1 and TCF-4 have been defined within the mouse MYC promoter (Hu and Rosenblum, 2005) and in Drosophila these two pathways converge on neighboring elements (Riese et al., 1997) . Another group of factors that engage in cooperative interactions are members of the homeodomain family. LEF/TCFs cooperate with Pitx2 and b-catenin to activate the LEF1 promoter (Vadlamudi et al., 2005) , with Alx4 to activate the NCAM promoter (Boras and Hamel, 2002) , with Cdx-1 to activate the CDX1 promoter (Beland et al., 2004) , and with homeoprotein PAL-1/Caudal in C. elegans (Maduro et al., 2005) . With the exception of the latter report in worms, all these interactions were detected with LEF-1; other family members were not tested, but it could be that LEF-1 is especially context-dependent because it is never expressed as an isoform with two DNA-binding domains. One notable example of LEF-1 specificity is microphthalmia-associated transcription factor (MITF). MITF cooperates specifically with LEF-1 to upregulate transcription of targets in melanocytes including its own MITF promoter Yasumoto et al., 2002) . Interaction with MITF requires both the NLS of LEF-1 and the CRD, and since the CRD is the least well-conserved region among LEF/TCFs, interaction with this portion of LEF-1 is likely to be the basis for the unique interaction. Interestingly, MITF expression in migrating neural crest cells of zebrafish requires LEF-1 and requires Nrarp, an ankyrin repeat protein that binds to the HMG DNA-binding domain of LEF-1 and prevents its ubiquitination and degradation (Dorsky et al., 2000; Ishitani et al., 2005) .
LEF/TCF co-repressors
All LEF/TCFs recruit Groucho/TLE for transcription repression via a region between the middle of the CRD and the end of the protein (Brantjes et al., 2001; Daniels and Weis, 2005) . More recent work has narrowed the interaction within the CRD near the internal alternatively spliced exon (Arce, L, in preparation). A secondary b-catenin-binding site has recently been discovered in the CRD as well, suggesting that overlapping binding sites set up competitive interactions between b-catenin and Groucho/TLE (Daniels and Weis, 2005) . Indeed, based on the early studies of Siamois expression in Xenopus, a model for competition between b-catenin and repressors was proposed . In this model, LEF/TCF . Groucho/TLE complexes are bound to gene targets until Wnt signals direct b-catenin to competitively displace Groucho/ TLE. Competitive interactions between b-catenin and Groucho/TLE can be demonstrated with purified proteins (Daniels and Weis, 2005) , and experiments in mouse myoblast and human colon cancer cells show that b-catenin and TLE proteins occupy endogenous gene targets in mutually exclusive patterns (Sierra et al., 2006) . Of course, the diversity in LEF/TCF isoforms means that the competition model only works for fulllength LEF/TCFs, not for truncated LEF/TCFs that do not have a b-catenin-binding domain (dnLEF/TCFs; Figure 1 ). Target genes occupied by dnLEF/ TCF . Groucho/TLE repressor complexes would be more refractory to b-catenin activation until the entire complex was displaced by full-length LEF/TCFs competing for binding to the WRE. The dynamics of this exchange is completely unknown. Interestingly, simple competitive displacement of b-catenin by Groucho/TLE proteins may not be occurring in vivo. At least in colon cancer cells, b-catenin is bound to the c-MYC target gene even though there is plenty of Groucho/TLE in the nucleus (Sierra et al., 2006) (and see below). Clearly, there are many unknowns about these complexes: (1) whether LEF/TCFs are bound to Wnt target genes all the time, (2) whether they each set up identical Groucho/TLE complexes for repression, and (3) whether other co-repressors influence these interactions.
LEF/TCFs engage in other forms of transcription repression and, unlike for Groucho, there may be differences among family members. For example, in Xenopus, xTCF-3 works with the co-repressor Kaiso, a sequence-specific DNA-binding protein (CTGCnA) and member of the BTB/POZ family (van Roy and McCrea, 2005) . Kaiso-binding sites are found near WREs in target genes such as Siamois where Kaiso antagonizes the recruitment of b-catenin to WREs and then cooperates with xTCF-3 to repress transcription (Park et al., 2005; Spring et al., 2005) . Kaiso specifically requires xTCF-3 because even though other LEF/TCFs are expressed in these cells, depletion of xTCF-3 by siRNA knockdown relieves repression of Siamois. The basis for this specificity is not known, but the unique CRD and/or E-tail of xTCF-3 is likely to be important. Another LEF/TCF co-repressor, CtBP, was identified through yeast two hybrid screens using the unique TCF-3 and TCF-4 E-tails as bait (Brannon et al., 1999; Valenta et al., 2003) . CtBP is a well-known non-DNAbinding repressor protein that recognizes a small peptide motif (PLSLxxK) in these E-tails, and binding is detected in in vitro binding assays (Brannon et al., 1999; Valenta et al., 2003) . These interactions imply that CtBP binds directly to TCF-3 and TCF-4 to repress transcription in vivo. Indeed, early reports on the repressive actions of maternal xTCF-3 in Xenopus embryos suggested that CtBP directly interacts with xTCF-3 (Brannon et al., 1997; Brannon et al., 1999) . However, unlike Groucho, the notion of CtBP as a directly interacting co-repressor is far from settled. The repressive actions of TCF-3 in mouse skin and embryonic stem cells do not need the C-terminal E tail or its CtBP-binding motifs (Merrill et al., 2001; Pereira et al., 2006) , and the repressive actions of xTCF-3 during zygotic Wnt signaling in Xenopus do not need the Diverse transcription regulation by LEF/TCFs L Arce et al E tail . In Drosophila, CtBP co-represses a subset of Wnt target genes, but not through direct recruitment via dTCF, but through independent mechanisms (Fang et al., 2006) . Finally, in mammalian cells, CtBP represses Wnt targets, not through a direct interaction with TCF, which could not be detected in vivo, but through interaction with Adenomatous Polyposis Coli (APC) in a complex that diverts bcatenin from gene targets (Hamada and Bienz, 2004) . In an elegant series of experiments in NIH 3T3 and colon cancer cells, Sierra et al. (2006) showed that APC . CtBP trafficks to LEF/TCF . b-catenin complexes bound to the c-MYC enhancer, associates with these complexes transiently, and then clears b-catenin from them for rapid exit from the nucleus. These actions happen before, and seem necessary for the subsequent association of Groucho/TLEs with enhancer-bound LEF/ TCFs. So, if CtBP and TCFs cannot be co-immunoprecipitated from cell extracts, if CtBP association with Wnt targets can be independent of TCFs, and if there are multiple examples where the E-tail is not needed for repression, is CtBP ever a directly interacting co-repressor with TCF-3 and TCF-4? The answer is maybe, and the evidence is circumstantial, but nevertheless worth noting. First, the putative CtBP interaction motifs in the TCF-3 and TCF-4 E-tails are conserved and show strong homology to other known CtBP interaction motifs. Also, deletion of these motifs or mutation by amino-acid substitution has consequences. For example, loss of the two motifs from the E-tail of a xLEF/xTCF-3 chimera relieves repressive activity in Siamois reporter assays in Xenopus (albeit, not in the context of full-length xTCF-3), and loss of the two motifs from the E-tail of TCF-4 disrupts its colocalization in nuclear dots with the BTB/POZ antagonist HIC1 (see below in LEF/TCF antagonists) and CtBP (Valenta et al., 2006) . Interestingly, HIC1 and CtBP directly interact in vitro and in vivo and HIC1 and TCF-4 also interact directly (Deltour et al., 2002; Stankovic-Valentin et al., 2006) . So, even if the bulk of the evidence favors indirect CtBP interactions with TCFs, this protein is so often linked to Wnt target gene regulation via different mechanistic modes, it is worth considering that in specialized contexts, the 'CtBP motifs' in the E-tails of TCF-3 and TCF-4 might be relevant. The motifs could engage in transient CtBP interactions within the context of larger complexes, or they might be more relevant to patterns of antagonism as opposed to co-repression. Lastly, the unquestionably direct LEF/TCF interacting transcription co-activator, b-catenin, can in fact participate in transcription repression. In osteoblast cells, the Runx2 activator is inhibited when it interacts with LEF-1 bound to a neighboring WRE (Kahler and Westendorf, 2003) . In this situation, Runx2 remains bound to its site, and repression is optimal when b-catenin is present. In Drosophila, ovo/svb and dpp expression are repressed by Wnt signaling in a tissue-specific manner, and recent work suggests that at least for dpp, direct binding of TCF . b-catenin (dTCF/arm) complexes to WREs is essential for repression (Theisen et al., submitted) , (Theisen et al., 1996; Payre et al., 1999) . Likewise, LEF-1 binds to WREs in the E-cadherin promoter and cooperates with b-catenin to repress transcription, an activity shown in keratinocytes but with obvious relevance to cancer (Jamora et al., 2003) . In the latter two examples, b-catenin recruitment is critical. Whether this novel mode of b-catenin action differs with respect to the LEF/TCF isoform recruiting it to the gene target is a complete unknown, as is the understanding of how this wellknown activator participates in transcription repression.
LEF/TCF antagonists
Three modes of antagonism modulate Wnt signaling strength in the nucleus, (1) isoforms of antagonizing LEF/ TCFs, (2) proteins that act upon LEF/TCFs to prevent their activity and (3) covalent modification of LEF/TCFs.
Antagonizing LEF/TCFs LEF/TCF loci produce antagonizing isoforms that limit Wnt signaling by preventing b-catenin access to targets. LEF1 and TCF7 genes (producing LEF-1 and TCF-1, respectively) each contain an alternative promoter in the second intron that produces truncated mRNAs missing coding sequences for the b-catenin-binding domain (Figure 1 ) Hovanes et al., 2001) . Such isoforms are commonly referred to as dominant negative LEF-1 (dnLEF-1) and dominant negative TCF-1 (dnTCF-1) because, even though the 'dominant negative' moniker is not accurate (LEF/TCFs bind as monomers to DNA), the name conveys that dnLEF/TCFs prevent activation of Wnt targets by competing for binding to WREs. Dominant negative isoforms are co-expressed with their full-length counterparts, and since the actions of b-catenin/LEF/TCF complexes drive cell proliferation and survival, dnLEF/ TCFs could have an important moderating influence on cell growth and differentiation (Hovanes et al., 2001; Weerkamp et al., 2006) . Four examples support this important prediction. First, deletion of the mouse TCF-1 gene leads to adenoma formation in intestine and breast tissues (Roose et al., 1999) . Given that loss of TCF-4 causes depletion of stem cells in the intestine, the opposite TCF-1 phenotype suggests that TCF-1 functions as a tumor suppressor. In fact, the predominant TCF forms in intestine are predicted to be dnTCF-1 and FL-TCF4; if this is true, it is possible that dnTCF-1 provides a tumor suppressor function by opposing the actions of FL-TCF-4 (Syed et al., submitted), (Roose et al., 1999) . If this is true, its role must be disrupted or circumvented in colon tumors. Interestingly, full-length LEF-1 is aberrantly expressed in approximately 80% of colon cancers (Hovanes et al., 2001; Li et al., 2006) . In this case, the promoter for FL-LEF-1 is aberrantly activated by the overactive Wnt signal in the cancer, and the promoter for dnLEF-1 is directly silenced. It is not known how much full-length LEF-1 contributes to cancer progression, but the fact that its opposing dominant negative isoform is Diverse transcription regulation by LEF/TCFs L Arce et al actively suppressed is telling. A third example comes from the discovery of mono-allelic mutations in the LEF1 locus in human sebaceous tumors (Takeda et al., 2006) . These mutations occur in the b-catenin-binding domain and essentially create a 'dnLEF-1' that can interfere with full-length LEF-1 produced from the wild-type allele as well as other co-expressed TCFs. Interestingly, expression of mutant 'dnLEF-1' represses Wnt target gene expression and upregulates sebocyte markers and differentiation. Finally, studies of TCF-1 expression in T lymphocytes show that the FL-TCF-1:dnTCF-1 ratio changes when lymphocytes mature and when naı¨ve CD8 þ T cells are activated (Weerkamp et al., 2006; Willinger et al., 2006) . These switches in isoform abundance are likely to play important roles in proliferation and survival. How general is the full-length and dominant negative isoform arrangement for LEF/TCFs? Thus far, there is no data for dominant negative isoforms in earlier organisms, but LEF/TCF genes in Xenopus carry a corresponding internal methionine, and while only dnLEF-1 and dnTCF-1 have been detected in mammalian systems, there are hints that the TCF7L2 locus might produce dnTCF-4 (Duval et al., 2000; Shulewitz et al., 2006) . At least one other inhibitory isoform of LEF/TCFs can be produced. An alternative splicing event in the middle of the TCF7L2 gene produces a translation stop codon before the HMG DNA-binding domain (Kennell et al., 2003) (TCF-4N; Figure 1 ). Overexpression of TCF-4N in preadipocytes inhibits WRE-based activation by squelching b-catenin from LEF/TCFs and redirecting it to nuclear hormone receptor SF-1 and the bHLH/LZ factor C/EBPa (Kennell et al., 2003) . The abundance of this form relative to other forms is not yet known, and its role has been explored only by overexpression studies, but in these experiments TCF-4N promotes adipocyte differentiation.
Heterologous antagonists
Numerous factors limit the activity of b-catenin . LEF/ TCF complexes (see references in Waterman (2004) ), and of these, several bind to specific LEF/TCFs or they covalently modify them. HIC1 (in an unusual convergence of nomenclature, three proteins discussed in this review, HIC1, HIC5 and HIC, are three completely different proteins; a BTB/POZ protein, LIM domain protein and I-mfa protein, respectively) is the Kaisorelated BTB/POZ family member that binds directly to CtBP (mentioned above in LEF/TCF co-repressors). But instead of acting as a Kaiso-like repressor, HIC1 apparently antagonizes TCF-4 through sequestration to novel dot structures in the nucleus (Deltour et al., 2002; van Roy and McCrea, 2005; Valenta et al., 2006) . CtBP is important for this effect as a mutant HIC1 missing its CtBP-binding motif cannot redirect TCF-4 to nuclear dots despite an intact HIC1/TCF-4 interaction (Valenta et al., 2006) . Likewise, the CtBP-binding motifs in the TCF-4 E tail are important for co-localization with HIC1 even though a direct interaction between CtBP and wild-type TCF-4 cannot be detected. Independent CtBP interactions by both HIC1 and TCF-4 seem to be important for the antagonistic effect, a strong hint that a larger complex is involved. Loss of CtBP/ TCF-4 interactions might be relevant to cancer because TCF-4 and CtBP co-localize in the nuclei of normal colon cells, but not in some colon cancers where, interestingly, frameshift mutations destroy the part of the E-tail containing the CtBP-binding motifs (Duval et al., 1999; Cuilliere-Dartigues et al., 2006) .
HIC5, a LIM domain protein known for its coactivator action with steroid hormone receptors, binds to the alternative exon region in the CRD and inhibits LEF/TCF . b-catenin activation of Wnt reporter genes (Ghogomu et al., 2006) . This effect is not understood mechanistically, but it may be an important connection to steroid hormone receptor pathways. LEF/TCF isoforms that function primarily as repressors (e.g. TCF-3 and TCF-4 with LVPQ and SLVSS motifs) inhibit steroid hormone receptor activity and HIC5 augments this repression. Other studies suggest that TCFs and nuclear hormone receptors directly interact, but with varying outcomes of activation or repression and so the in vivo relevance of these interactions has not yet been defined (Amir et al., 2003; El-Tanani et al., 2004; Ghogomu et al., 2006) . There are other antagonists that bind to LEF/TCFs and counteract their activities. The proteins I-mfa and HIC (XIC in Xenopus) bind to xTCF-3 and hLEF-1 HMG domains and prevent DNA binding, and the Leucine Zipper/PDZ Frodo proteins bind to xTCF-3 and inhibit activity (Snider et al., 2001; Kusano and Raab-Traub, 2002; Hikasa and Sokol, 2004; Snider and Tapscott, 2005) . Neither of these interactions have been compared among LEF/TCF family members or isoforms, and their mechanism of action is not yet defined (Figure 2 ).
Covalent modifications
LEF/TCFs can be antagonized by covalent modifications that disrupt or enable interacting partners. In Drosophila, the transcription co-activator dCBP can bind to the HMG DNA-binding domain of dTCF/pan and acetylate a lysine residue in the Armadillo/ b-catenin-binding domain to interfere with the binding (Waltzer and Bienz, 1998) . In C. elegans, POP-1 is acetylated by CBP/p300 near the HMG domain, and this modification increases nuclear import (Gay et al., 2003) . Both acetylation events result in decreases in Wnt target gene expression; whether this is true in vertebrates is not yet known, but it is interesting to point out that the same exact lysine residue (K25) that is acetylated in Drosophila is SUMOylated in mouse LEF-1 by the E3 ligase PIASy (TCF-1 and TCF-3 do not have the analogous residue). Initial experiments suggested that SUMO modification leads to a similar inhibitory outcome (Sachdev et al., 2001) . However, repression might be cell type-specific because others detect PIASy SUMOylation of TCF-4 in the HMG DNA-binding domain, and this increases activation (Yamamoto et al., 2003) . Phosphorylation is another modification with negative consequences. Casein kinase 1 phosphorylation of LEF-1 on a serine in the b-catenin-binding domain (Behrens et al., 1996; Brunner et al., 1997; Daniels & Weis, 2005; Graham et al., 2000; Huber et al., 1996; Molenaar et al., 1996; van de Wetering et al., 1997) -catenin (Kolligs et al., 2000; Miravet et al., 2002) YCTTTGWW~1 0 -9 M; (Giese et al., 1991; Love et al., 1995; van Beest et al., 2000; van de Wetering et al., 1997; Waterman et al., 1991) Double-strand DNA Atcha et al., 2006, submitted Importin alpha (Prieve et al., 1996; Prieve et al., 1998) SMADs (Nishita et al., 2000) Cdx1 (Beland et al., 2004) Alx4 (Boras & Hamel, 2002) Pitx2 (Vadlamudi et al., 2005) Ets (Carlsson et al., 1993; Giese et al., 1995; Sheridan et al., 1995) MITF LEF-1 only; Aly LEF-1; (Bruhn et al., 1997) p300 (Hecht & Stemmler, 2003) Groucho/TLE (Brantjes et al., 2001; Daniels & Weis, 2005; Levanon et al., 1998; Roose et al., 1998) CtBP PLSLSxK, PLSLVTK (TCF3, TCF4) (Brannon et al., 1999; Valenta et al., 2003) Kaiso (Park et al., 2005) Runx2 (Kahler & Westendorf, 2003) HIC5 (Ghogomu et al., 2006) HIC1 (Deltour et al., 2002; Valenta et al., 2006) I-mfa, HIC (Kusano & Raab-Traub, 2002; Snider & Tapscott, 2005) Frodo (Hikasa & Sokol, 2004) dCBP Ac-K25, dTCF; (Waltzer & Bienz, 1998) PIASy Sumo-K25, LEF-1; Sumo-K297, TCF-4 (Sachdev et al., 2001 ) (Yamamoto et al., 2003) NLK/LIT1
Phosphorylates POP-1, LEF-1, TCF-4 (Ishitani et al., 2003; Lo et al., 2004) PAR-5(14-3-3)
recognizes phosphorylated POP-1 (Lo et al., 2004) Casein kinase I EISHPE in LEF-1; (Hammerlein et al., 2005) ;CK interaction not mapped
Casein kinase 2 SSSDS in TCF-4; (Miravet et al., 2002) • Diverse transcription regulation by LEF/TCFs L Arce et al disrupts binding and casein kinase 2 phosphorylation of a downstream residue in TCF-4 disrupts g-catenin binding (Pukrop et al., 2001; Miravet et al., 2002; Hammerlein et al., 2005) . These residues are not conserved in other family members, hinting at intriguing potential for differential regulation. However, whether casein kinase phosphorylation of LEF/TCFs occurs with endogenous proteins and whether phosphorylation plays a relevant role in their in vivo function, still needs to be determined. The Nemo-like kinases (NLK) antagonize LEF/TCF action by phosphorylating sites in the CRD Meneghini et al., 1999) . In vertebrates, NLK phosphorylates LEF-1 and TCF-4 and in C. elegans, the orthologous LIT-1 phosphorylates POP-1 (Ishitani et al., 2003; Lo et al., 2004) . Phosphorylation of POP-1 creates a recognition motif for a 14-3-3 protein (PAR-5) that tethers it to the nuclear export protein CRM-1 for rapid export from nuclei (Lo et al., 2004) . In the case of mammalian NLK and LEF/TCFs, phosphorylation inhibits DNA binding -a surprising finding given that the modifications occur far outside the HMG DNA-binding domain (Ishitani et al., 2003) . Subcellular localization was not specifically examined in the vertebrate studies, but LEF/TCFs were abundant in nuclear extracts from cells with activated NLK, so the mechanism behind the decreased binding activity is still not known. How is the NLK/LIT-1 pathway regulated? In worms, Wnt signaling triggers the activation of LIT-1 via the alternative catenin WRM-1, and in vertebrates the Wnt5a/Ca þ 2 pathway activates NLK, suggesting that LEF/TCFs are regulated by certain Wnt signals in a feedback loop. As TCF-1 and TCF-3 do not have the NLK phosphorylation motifs, they might be impervious to negative regulation.
Summary
This review has provided examples to underscore how LEF/TCFs are context-dependent regulators. They cooperate with factors to regulate transcription independent of Wnt signaling as well as to mediate (or suppress) Wnt signaling. Their roles are not just as activators, but some family members such as TCF-3, appear to function primarily as a repressor. Their modest DNA binding strength and specificity means that Wnt signals must rely on cross-talk with other factors to reach the right set of target genes. This complexity is one way the Wnt pathway can be finetuned for signal specificity and strength in the nucleus. Wnt signaling in earlier diverging systems such as flies and worms relies on a single LEF/TCF family member to carry out changes in gene expression in the nucleus and, as discussed here, these ancestral forms may be acting more independently than their vertebrate counterparts. Thus, in vertebrates, the expansion of the family into multiple members, dominant negative isoforms, and alternatively spliced isoforms creates complex signals inside the nucleus, not simple digital ON/ OFF responses to b-catenin. The use of artificial Wnt reporters in transgenics (i.e. TOPGAL, SuperTOPGAL) has been highly useful for tracking the overall 'pure' activating Wnt signal, but it does not reflect the actual regulation by LEF/TCFs at individual gene targetsactivities that may range from activation to repression within the same nucleus. There are, of course, many unknowns. The transcription activating and importantly, the repressing complexes that assemble at gene targets and the precise events that negotiate switches between these complexes are some of the most pressing and interesting. Till now, we have relied on serendipitous discoveries of cooperative/antagonistic partners at single gene targets or single cell types, but at this pace the full picture will never be completed. Genomewide RNAi screens might have uncovered important interactions, but because these screens use artificial reporter plasmids as a readout, they are unlikely to be efficient discovery tools for contextspecific LEF/TCF interactions. Instead, in silico analysis of LEF/TCF-binding sites in promoters and enhancers coupled with genomewide ChiP-ChiP and protein network interactions specific for each family member, will provide a better overall picture of how this family has diversified.
